The clustering of risk factors for cardiovascular disease (CVD) and non-ins
ulin-dependent diabetes mellitus (NIDDM) in obese patients may be attributa
ble to a disturbed metabolism caused by hypophosphataemia. A low serum phos
phate (S-P) level may be a limiting factor for glucose metabolism and may a
ccount for hyperglycaemia, with an increased risk of NIDDM and hypertension
and consequent increased risk of stroke. Low S-HDL levels, known to exist
in the metabolic syndrome, as well as high serum triglycerides may also hav
e been the results of phosphate depletion. The hypothesis presents a new se
rious disturbance which accounts for the dyslipidaemia, hyperglycaemia and
the hypertension in metabolic syndrome. The proposed causal relationship be
tween low S-P and the clustering of risk factors is based on results from a
cross-sectional study of obese patients, where low S-P was associated with
high body mass index (BMI), high blood glucose (B-glu), high systolic bloo
d pressure (SBP), high diastolic blood pressure (DBP), but low serum high d
ensity lipoprotein (S-HDL) and serum magnesium (S-Mg) levels. Knowledge fro
m experimental and clinical studies on hypophosphataemia and/or phosphate d
epletion are referred to when discussing the hypothesis. (C) 2001 Harcourt
Publishers Ltd.